{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T10:15:09Z","timestamp":1772792109257,"version":"3.50.1"},"reference-count":51,"publisher":"Impact Journals, LLC","issue":"36","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2015,11,17]]},"DOI":"10.18632\/oncotarget.5731","type":"journal-article","created":{"date-parts":[[2015,10,28]],"date-time":"2015-10-28T14:28:44Z","timestamp":1446042524000},"page":"38952-38966","source":"Crossref","is-referenced-by-count":17,"title":["The BH3-mimetic gossypol and noncytotoxic doses of valproic acid induce apoptosis by suppressing cyclin-A2\/Akt\/FOXO3a signaling"],"prefix":"10.18632","volume":"6","author":[{"given":"Gao-Xiang","family":"Zhao","sequence":"first","affiliation":[{"name":"Department of Immunobiology, College of Life Science and Technology, Jinan University, Guangzhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-Hui","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Cell Biology, College of Life Science and Technology, Jinan University, Guangzhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Pan","sequence":"additional","affiliation":[{"name":"Department of Immunobiology, College of Life Science and Technology, Jinan University, Guangzhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiu-Ru","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Immunobiology, College of Life Science and Technology, Jinan University, Guangzhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei-Yun","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Immunobiology, College of Life Science and Technology, Jinan University, Guangzhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji-Ye","family":"Cai","sequence":"additional","affiliation":[{"name":"Department of Chemistry, College of Life Science and Technology, Jinan University, Guangzhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong-Yun","family":"Ouyang","sequence":"additional","affiliation":[{"name":"Department of Immunobiology, College of Life Science and Technology, Jinan University, Guangzhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xian-Hui","family":"He","sequence":"additional","affiliation":[{"name":"Department of Immunobiology, College of Life Science and Technology, Jinan University, Guangzhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2015,10,16]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1200\/JCO.2007.13.9717","article-title":"Anti-apoptosis mechanisms in malignant gliomas","volume":"26","author":"Kieran","year":"2008","journal-title":"J Clin Oncol"},{"key":"2","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/1756-9966-30-87","article-title":"Apoptosis in cancer: from pathogenesis to treatment","volume":"30","author":"Wong","year":"2011","journal-title":"J Exp Clin Cancer Res"},{"key":"3","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ejphar.2009.10.011","article-title":"Epigenetics and cancer treatment","volume":"625","author":"Hansen","year":"2009","journal-title":"Eur J Pharmacol"},{"key":"4","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/nbt1272","article-title":"Dimethyl sulfoxide to vorinostat: development of this histone deacetylase inhibitor as an anticancer drug","volume":"25","author":"Breslow","year":"2007","journal-title":"Nat Biotechnol"},{"key":"5","doi-asserted-by":"crossref","first-page":"4504","DOI":"10.18632\/oncotarget.2056","article-title":"New histone deacetylase inhibitors improve cisplatin antitumor properties against thoracic cancer cells","volume":"5","author":"Blanquart","year":"2014","journal-title":"Oncotarget"},{"key":"6","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1158\/1541-7786.MCR-10-0471","article-title":"Low-dose valproic acid enhances radiosensitivity of prostate cancer through acetylated p53-dependent modulation of mitochondrial membrane potential and apoptosis","volume":"9","author":"Radany","year":"2011","journal-title":"Mol Cancer Res"},{"key":"7","doi-asserted-by":"crossref","first-page":"21507","DOI":"10.18632\/oncotarget.4242","article-title":"Combining BET and HDAC inhibitors synergistically induces apoptosis of melanoma and suppresses AKT and YAP signaling","volume":"6","author":"Gallagher","year":"2015","journal-title":"Oncotarget"},{"key":"8","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1158\/1535-7163.MCT-08-0333","article-title":"Natural BH3 mimetic (\u2212)-gossypol chemosensitizes human prostate cancer via Bcl-xL inhibition accompanied by increase of Puma and Noxa","volume":"7","author":"Xu","year":"2008","journal-title":"Mol Cancer Ther"},{"key":"9","doi-asserted-by":"crossref","first-page":"12862","DOI":"10.18632\/oncotarget.3868","article-title":"New dimension in therapeutic targeting of BCL-2 family proteins","volume":"6","author":"Billard","year":"2015","journal-title":"Oncotarget"},{"key":"10","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0006-2952(03)00248-X","article-title":"Molecular mechanism of gossypol-induced cell growth inhibition and cell death of HT-29 human colon carcinoma cells","volume":"66","author":"Yang","year":"2003","journal-title":"Biochem Pharmacol"},{"key":"11","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1158\/1535-7163.197.4.2","article-title":"(\u2212)-Gossypol enhances response to radiation therapy and results in tumor regression of human prostate cancer","volume":"4","author":"Lippman","year":"2005","journal-title":"Mol Cancer Ther"},{"key":"12","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1182\/blood-2007-12-126946","article-title":"Gossypol, a BH3 mimetic, induces apoptosis in chronic lymphocytic leukemia cells","volume":"112","author":"Gandhi","year":"2008","journal-title":"Blood"},{"key":"13","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1097\/JTO.0b013e31822e2941","article-title":"A phase II study of AT-101 (Gossypol) in chemotherapy-sensitive recurrent extensive-stage small cell lung cancer","volume":"6","author":"California","year":"2011","journal-title":"J Thorac Oncol"},{"key":"14","first-page":"1019","article-title":"Oral gossypol in the treatment of metastatic adrenal cancer","volume":"76","author":"Reidenberg","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"15","doi-asserted-by":"crossref","first-page":"e690","DOI":"10.1038\/cddis.2013.191","article-title":"Gossypol and an HMT G9a inhibitor act in synergy to induce cell death in pancreatic cancer cells","volume":"4","author":"Wagner","year":"2013","journal-title":"Cell Death Dis"},{"key":"16","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1684\/ecn.2009.0159","article-title":"Combined gossypol and zoledronic acid treatment results in synergistic induction of cell death and regulates angiogenic molecules in ovarian cancer cells","volume":"20","author":"Uslu","year":"2009","journal-title":"Eur Cytokine Netw"},{"key":"17","doi-asserted-by":"crossref","first-page":"e50786","DOI":"10.1371\/journal.pone.0050786","article-title":"Combination therapy with gossypol reveals synergism against gemcitabine resistance in cancer cells with high BCL-2 expression","volume":"7","author":"Yong","year":"2012","journal-title":"PLoS One"},{"key":"18","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1016\/j.jprot.2011.06.016","article-title":"Valproic acid synergistically enhances the cytotoxicity of gossypol in DU145 prostate cancer cells: an iTRTAQ-based quantitative proteomic analysis","volume":"74","author":"He","year":"2011","journal-title":"J Proteomics"},{"key":"19","first-page":"1913","article-title":"New drugs in recurrent high grade gliomas","volume":"20","author":"Monfardini","year":"2000","journal-title":"Anticancer Res"},{"key":"20","first-page":"5870","article-title":"Fas-mediated apoptosis in human prostatic carcinoma cell lines occurs via activation of caspase-8 and caspase-7","volume":"58","author":"Cohen","year":"1998","journal-title":"Cancer Res"},{"key":"21","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1158\/1541-7786.MCR-09-0562","article-title":"The pan-Bcl-2 inhibitor (\u2212)-gossypol triggers autophagic cell death in malignant glioma","volume":"8","author":"Kogel","year":"2010","journal-title":"Mol Cancer Res"},{"key":"22","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/cdd.2010.74","article-title":"A natural BH3 mimetic induces autophagy in apoptosis-resistant prostate cancer via modulating Bcl-2-Beclin1 interaction at endoplasmic reticulum","volume":"18","author":"Xu","year":"2011","journal-title":"Cell Death Differ"},{"key":"23","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1093\/neuonc\/nop005","article-title":"Autophagy induced by valproic acid is associated with oxidative stress in glioma cell lines","volume":"12","author":"Chen","year":"2010","journal-title":"Neuro Oncol"},{"key":"24","first-page":"377","article-title":"Update on the treatment of cutaneous T-cell lymphoma (CTCL): Focus on vorinostat","volume":"1","author":"Vu","year":"2007","journal-title":"Biologics"},{"key":"25","doi-asserted-by":"crossref","first-page":"5541","DOI":"10.1038\/sj.onc.1210620","article-title":"Histone deacetylase inhibitors: molecular mechanisms of action","volume":"26","author":"Marks","year":"2007","journal-title":"Oncogene"},{"key":"26","doi-asserted-by":"crossref","first-page":"4389","DOI":"10.1073\/pnas.0430973100","article-title":"Domain-selective small-molecule inhibitor of histone deacetylase 6 (HDAC6)-mediated tubulin deacetylation","volume":"100","author":"Schreiber","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"27","first-page":"35","article-title":"Effect of gossypol on DNA synthesis and cell cycle progression of mammalian cells","volume":"44","author":"Rao","year":"1984","journal-title":"Cancer Res"},{"key":"28","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/nature13079","article-title":"Cell-cycle-regulated activation of Akt kinase by phosphorylation at its carboxyl terminus","volume":"508","author":"Gygi","year":"2014","journal-title":"Nature"},{"key":"29","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1242\/jcs.114.16.2903","article-title":"PKB\/Akt: a key mediator of cell proliferation, survival and insulin responses?","volume":"114","author":"Alessi","year":"2001","journal-title":"J Cell Sci"},{"key":"30","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1189\/jlb.1202629","article-title":"Decisions on life and death: FOXO Forkhead transcription factors are in command when PKB\/Akt is off duty","volume":"73","author":"Medema","year":"2003","journal-title":"J Leukoc Biol"},{"key":"31","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1083\/jcb.200303026","article-title":"FOXO transcription factors directly activate bim gene expression and promote apoptosis in sympathetic neurons","volume":"162","author":"Ham","year":"2003","journal-title":"J Cell Biol"},{"key":"32","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/349132a0","article-title":"Cyclin is degraded by the ubiquitin pathway","volume":"349","author":"Kirschner","year":"1991","journal-title":"Nature"},{"key":"33","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1038\/sj.cdd.4401251","article-title":"Induction of apoptosis in human osteosarcoma Saos-2 cells by the proteasome inhibitor MG132 and the protective effect of pRb","volume":"10","author":"Tesoriere","year":"2003","journal-title":"Cell Death Differ"},{"key":"34","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.4161\/cc.9.7.11254","article-title":"Novel combination of celecoxib and proteasome inhibitor MG132 provides synergistic antiproliferative and proapoptotic effects in human liver tumor cells","volume":"9","author":"Cervello","year":"2010","journal-title":"Cell Cycle"},{"key":"35","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s10238-011-0146-5","article-title":"Natural resistance to apoptosis correlates with resistance to chemotherapy in colorectal cancer cells","volume":"12","author":"Zhang","year":"2012","journal-title":"Clin Exp Med"},{"key":"36","doi-asserted-by":"crossref","first-page":"729","DOI":"10.18632\/oncotarget.1027","article-title":"FAM83B-mediated activation of PI3K\/AKT and MAPK signaling cooperates to promote epithelial cell transformation and resistance to targeted therapies","volume":"4","author":"Jackson","year":"2013","journal-title":"Oncotarget"},{"key":"37","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1038\/onc.2008.24","article-title":"FOXOs, cancer and regulation of apoptosis","volume":"27","author":"Tindall","year":"2008","journal-title":"Oncogene"},{"key":"38","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/sj.leu.2402824","article-title":"Involvement of PI3K\/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapy","volume":"17","author":"McCubrey","year":"2003","journal-title":"Leukemia"},{"key":"39","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1158\/0008-5472.CAN-12-2440","article-title":"Trastuzumab-resistant cells rely on a HER2-PI3K-FoxO-survivin axis and are sensitive to PI3K inhibitors","volume":"73","author":"Arteaga","year":"2013","journal-title":"Cancer Res"},{"key":"40","doi-asserted-by":"crossref","first-page":"3244","DOI":"10.1111\/febs.12303","article-title":"SERPINA3K induces apoptosis in human colorectal cancer cells via activating the Fas\/FasL\/caspase-8 signaling pathway","volume":"280","author":"Yang","year":"2013","journal-title":"FEBS J"},{"key":"41","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1080\/01926230701320337","article-title":"Apoptosis: a review of programmed cell death","volume":"35","author":"Elmore","year":"2007","journal-title":"Toxicol Pathol"},{"key":"42","doi-asserted-by":"crossref","first-page":"3870","DOI":"10.1158\/0008-5472.CAN-13-3440","article-title":"Loss of Cdk2 and cyclin A2 impairs cell proliferation and tumorigenesis","volume":"74","author":"Kaldis","year":"2014","journal-title":"Cancer Res"},{"key":"43","doi-asserted-by":"crossref","first-page":"333","DOI":"10.2165\/00003495-198938030-00001","article-title":"An overview of the clinical pharmacology and therapeutic potential of gossypol as a male contraceptive agent and in gynaecological disease","volume":"38","author":"Wu","year":"1989","journal-title":"Drugs"},{"key":"44","first-page":"91","article-title":"The inhibitory effects of gossypol on human prostate cancer cells-PC3 are associated with transforming growth factor beta1 (TGFbeta1) signal transduction pathway","volume":"24","author":"Lin","year":"2004","journal-title":"Anticancer Res"},{"key":"45","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0304-3835(96)04340-6","article-title":"Inhibition of human prostate cancer cells growth by gossypol is associated with stimulation of transforming growth factor-beta","volume":"107","author":"Lin","year":"1996","journal-title":"Cancer Lett"},{"key":"46","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/00001813-200003000-00009","article-title":"Structure-activity studies on gossypol in tumor cell lines","volume":"11","author":"Fish","year":"2000","journal-title":"Anticancer Drugs"},{"key":"47","first-page":"33","article-title":"The (\u2212)-enantiomer of gossypol possesses higher anticancer potency than racemic gossypol in human breast cancer","volume":"22","author":"Lin","year":"2002","journal-title":"Anticancer Res"},{"key":"48","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1200\/JCO.2006.08.6165","article-title":"Phase I trial of histone deacetylase inhibition by valproic acid followed by the topoisomerase II inhibitor epirubicin in advanced solid tumors: a clinical and translational study","volume":"25","author":"Daud","year":"2007","journal-title":"J Clin Oncol"},{"key":"49","doi-asserted-by":"crossref","first-page":"20","DOI":"10.4161\/auto.22397","article-title":"Autophagy is differentially induced in prostate cancer LNCaP, DU145 and PC-3 cells via distinct splicing profiles of ATG5","volume":"9","author":"Ren","year":"2013","journal-title":"Autophagy"},{"key":"50","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1158\/1535-7163.MCT-11-0559","article-title":"Sorafenib sensitizes (\u2212)-gossypol-induced growth suppression in androgen-independent prostate cancer cells via Mcl-1 inhibition and Bak activation","volume":"11","author":"He","year":"2012","journal-title":"Mol Cancer Ther"},{"key":"51","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.neulet.2014.12.054","article-title":"Valproic acid prevents retinal degeneration in a murine model of normal tension glaucoma","volume":"588","author":"Harada","year":"2015","journal-title":"Neurosci Lett"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.5731","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,15]],"date-time":"2023-08-15T17:21:17Z","timestamp":1692120077000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.5731"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,16]]},"references-count":51,"journal-issue":{"issue":"36","published-print":{"date-parts":[[2015,11,17]]}},"alternative-id":["5731","26517515"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.5731","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,16]]}}}